New Delhi [India], December 27 (ANI/Mediawire): Chronic Obstructive Pulmonary Disease, also known as COPD, is a progressive lung disease that compromises the lung's ability to function, thus making it harder for a person to breathe and hampering their health and productivity. The condition leads to swelling in individuals' airways and damage to their lungs due to exposure to toxins outside of the body, which restricts airflow and makes it more difficult for them to breathe. Statistics show that the disease impacts 1 in every 6 Indians, making it the second leading cause of disease burden in India right after heart disease. Globally, it is the third leading cause of death which has contributed to 3.23 million deaths as of 2019. Multiple factors can result in people developing COPD over time. According to Dr Satyanarayana Mysore, Consultant Pulmonologist, Bangalore said, "COPD is estimated to affect about 7.4 per cent of the Indian population. Factors like active and passive
On December 16, Regeneron said its cocktail drug had diminished potency against Omicron. But 13 days later, Cipla held a webinar to promote its use in India.